Subjective cognitive concerns, amyloid-b, and neurodegeneration in clinically normal elderly

Neurology

Volumn 85, Issue 1, 2015, Pages 56-62

  Amariglio, Rebecca E ^a,b   Mormino, Elizabeth C ^b   Pietras, Alison C ^a   Marshall, Gad A ^a,b   Vannini, Patrizia ^a,b   Johnson, Keith A ^a,b   Sperling, Reisa A ^a,b   Rentz, Dorene M ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; PITTSBURGH COMPOUND B;

AGED; AMYLOIDOSIS; ARTICLE; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; EPISODIC MEMORY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE DEGENERATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PET SCANNER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SECONDARY PREVENTION; SELF REPORT; SUBJECTIVE COGNITIVE CONCERN; ALZHEIMER DISEASE; COGNITION DISORDERS; METABOLISM; NEURODEGENERATIVE DISEASES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEURODEGENERATIVE DISEASES; POSITRON-EMISSION TOMOGRAPHY;

EID: 84936990554     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001712     Document Type: Article

References (40)

1. Jessen F, Amariglio RE, van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimers disease. Alzheimers Dement 2014; 10: 844-852
2. Knopman DS. Subjective cognitive impairment: fickle but fateful. Neurology 2012; 79: 1308-1309
3. Amariglio RE, Becker JA, Carmasin J, et al. Subjective cognitive complaints and amyloid burden in cognitively normal older individuals. Neuropsychologia 2012; 50: 2880-2886
4. Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ. Subjective cognition and amyloid deposition imaging: a Pittsburgh compound B positron emission tomography study in normal elderly individuals. Arch Neurol 2012; 69: 223-229
5. Jessen F, Feyen L, Freymann K, et al. Volume reduction of the entorhinal cortex in subjective memory impairment. Neurobiol Aging 2006; 27: 1751-1756
6. Saykin AJ, Wishart HA, Rabin LA, et al. Older adults with cognitive complaints show brain atrophy similar to that of amnestic MCI. Neurology 2006; 67: 834-842
7. van der Flier WM, van Buchem MA, Weverling-Rijnsburger AW, et al. Memory complaints in patients with normal cognition are associated with smaller hippocampal volumes. J Neurol 2004; 251: 671-675
8. Mosconi L, De Santi S, Brys M, et al. Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints. Biol Psychiatry 2008; 63: 609-618
9. Scheef L, Spottke A, Daerr M, et al. Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology 2012; 79: 1332-1339
10. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease. Alzheimers Dement 2011; 7: 280-292
11. Jack CR Jr, Knopman DS, Weigand SD, et al. An operational approach to national institute on aging-Alzheimers association criteria for preclinical Alzheimer disease. Ann Neurol 2012; 71: 765-775
12. Knopman DS, Jack CR Jr, Wiste HJ, et al. Short-Term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. Neurology 2012; 78: 1576-1582
13. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-2414
14. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
15. Yesavage JA, Brink TL, Rose TL, et al. Development and validation of a geriatric depression screening scale. J Psychiatry Res 1982-1983; 17: 37-49
16. Farias ST, Mungas D, Reed BR, et al. The measurement of everyday cognition (ECog): scale development and psychometric properties. Neuropsychology 2008; 22: 531-544
17. Gilewski MJ, Zelinski EM, Schaie KW. The Memory Functioning Questionnaire for assessment of memory complaints in adulthood and old age. Psychol Aging 1990; 5: 482-490
18. Amariglio RE, Townsend MK, Grodstein F, Sperling RA, Rentz DM. Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc 2011; 59: 1612-1617
19. Go RC, Duke LW, Harrell LE, et al. Development and validation of a structured telephone interview for dementia assessment (STIDA): the NIMH Genetics initiative. J Geriatr Psychiatry Neurol 1997; 10: 161-167
20. Hedden T, Mormino EC, Amariglio RE, et al. Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults. J Neurosci 2012; 32: 16233-16242
21. Amariglio RE, Frishe K, Olson LE, et al. Validation of the face name associative memory exam in cognitively normal older individuals. J Clin Exp Neuropsychol 2012; 34: 580-587
22. Rentz DM, Amariglio RE, Becker JA, et al. Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia 2011; 49: 2776-2783
23. Masur DM, Fuld PA, Blau AD, Thal LJ, Levin HS, Aronson MK. Distinguishing normal and demented elderly with the selective reminding test. J Clin Exp Neuropsychol 1989; 11: 615-630
24. Rentz DM, Locascio JJ, Becker JA, et al. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol 2010; 67: 353-364
25. Johnson KA, Gregas M, Becker JA, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 2007; 62: 229-234
26. Mormino EC, Betensky RA, Hedden T, et al. Amyloid and APOE epsilon4 interact to influence short-Term decline in preclinical Alzheimer disease. Neurology 2014; 82: 1760-1767
27. Landau SM, Harvey D, Madison CM, et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 2011; 32: 1207-1218
28. Mormino EC, Betensky RA, Hedden T, et al. Synergistic effect of beta-Amyloid and neurodegeneration on cognitive decline in clinically Normal individuals. JAMA Neurol 2014; 71: 1379-1385
29. Rowe CC, Ellis KA, Rimajova M, et al. Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 2010; 31: 1275-1283
30. Chetelat G, Villemagne VL, Bourgeat P, et al. Relationship between atrophy and beta-Amyloid deposition in Alzheimer disease. Ann Neurol 2010; 67: 317-324
31. van Harten AC, Smits LL, Teunissen CE, et al. Preclinical AD predicts decline in memory and executive functions in subjective complaints. Neurology 2013; 81: 1409-1416
32. Kryscio RJ, Abner EL, Cooper GE, et al. Self-reported memory complaints: implications from a longitudinal cohort with autopsies. Neurology 2014; 83: 1359-1365
33. Comijs HC, Deeg DJ, Dik MG, Twisk JW, Jonker C. Memory complaints; the association with psycho-Affective and health problems and the role of personality characteristics: a 6-year follow-up study. J Affect Disord 2002; 72: 157-165
34. Minett TS, Da Silva RV, Ortiz KZ, Bertolucci PH. Subjective memory complaints in an elderly sample: a crosssectional study. Int J Geriatr Psychiatry 2008; 23: 49-54
35. Gerritsen L, Comijs HC, van der Graaf Y, Knoops AJ, Penninx BW, Geerlings MI. Depression, hypothalamic pituitary adrenal axis, and hippocampal and entorhinal cortex volumes: the SMART Medea study. Biol Psychiatry 2011; 70: 373-380
36. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999; 19: 5034-5043
37. Donovan NJ, Hsu DC, Dagley AS, et al. Depressive symptoms and biomarkers of Alzheimers disease in cognitively normal older adults. J Alzheimers Dis 2015; 46: 63-73
38. Jonker C, Geerlings MI, Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatric Psychiatry 2000; 15: 983-991
39. van Oijen M, de Jong FJ, Hofman A, Koudstaal PJ, Breteler MM. Subjective memory complaints, education, and risk of Alzheimers disease. Alzheimers Dement 2007; 3: 92-97
40. Buckley RF, Saling MM, Irish M, et al. Autobiographical narratives relate to Alzheimers disease biomarkers in older adults. Int Psychogeriatr 2014; 26: 1737-1746